Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.110
+0.040 (3.74%)
At close: Nov 21, 2024, 4:00 PM
1.100
-0.010 (-0.90%)
After-hours: Nov 21, 2024, 4:35 PM EST
Immunic Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Cash & Equivalents | 59.07 | 46.67 | 106.75 | 86.86 | 127.45 | 29.37 | Upgrade
|
Short-Term Investments | - | - | 9.63 | - | - | - | Upgrade
|
Cash & Short-Term Investments | 59.07 | 46.67 | 116.37 | 86.86 | 127.45 | 29.37 | Upgrade
|
Cash Growth | -1.04% | -59.89% | 33.97% | -31.85% | 333.97% | 124.67% | Upgrade
|
Other Receivables | 0.82 | 2.48 | 2.66 | 2.15 | 1.64 | 0.76 | Upgrade
|
Receivables | 0.82 | 2.48 | 2.66 | 2.15 | 1.64 | 0.76 | Upgrade
|
Prepaid Expenses | 2.62 | 2.31 | 5.61 | 15.98 | 4.65 | 1.31 | Upgrade
|
Other Current Assets | 0.76 | 1.07 | 1.23 | - | - | 0.8 | Upgrade
|
Total Current Assets | 63.27 | 52.53 | 125.86 | 104.99 | 133.75 | 32.23 | Upgrade
|
Property, Plant & Equipment | 1.5 | 1.77 | 1.85 | 1.1 | 1.1 | 0.71 | Upgrade
|
Goodwill | - | - | - | 32.97 | 32.97 | 32.97 | Upgrade
|
Other Long-Term Assets | - | - | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade
|
Total Assets | 64.76 | 54.3 | 127.75 | 139.1 | 167.86 | 65.96 | Upgrade
|
Accounts Payable | 6.04 | 5.1 | 4.28 | 3.75 | 3.7 | 2.42 | Upgrade
|
Accrued Expenses | 16.25 | 18.66 | 7.99 | 7.07 | 4.32 | 3.3 | Upgrade
|
Current Portion of Leases | 0.71 | 0.7 | 0.57 | 0.41 | 0.3 | - | Upgrade
|
Current Unearned Revenue | - | - | - | - | - | 1.01 | Upgrade
|
Other Current Liabilities | 0.36 | 0.27 | 0.24 | 0.18 | 0.08 | 0.34 | Upgrade
|
Total Current Liabilities | 23.36 | 24.73 | 13.08 | 11.4 | 8.4 | 7.07 | Upgrade
|
Long-Term Leases | 0.19 | 0.64 | 0.99 | 0.58 | 0.68 | 0.52 | Upgrade
|
Total Liabilities | 23.54 | 25.37 | 14.07 | 11.99 | 9.08 | 7.59 | Upgrade
|
Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 523.55 | 436.06 | 427.93 | 324.24 | 266.82 | 119.65 | Upgrade
|
Retained Earnings | -486.22 | -410.89 | -317.28 | -196.87 | -103.93 | -59.91 | Upgrade
|
Comprehensive Income & Other | 3.89 | 3.76 | 3.04 | -0.25 | -4.11 | -1.37 | Upgrade
|
Total Common Equity | 41.22 | 28.93 | 113.68 | 127.12 | 158.79 | 58.36 | Upgrade
|
Shareholders' Equity | 41.22 | 28.93 | 113.68 | 127.12 | 158.79 | 58.36 | Upgrade
|
Total Liabilities & Equity | 64.76 | 54.3 | 127.75 | 139.1 | 167.86 | 65.96 | Upgrade
|
Total Debt | 0.9 | 1.33 | 1.56 | 0.99 | 0.98 | 0.52 | Upgrade
|
Net Cash (Debt) | 58.17 | 45.34 | 114.81 | 85.87 | 126.48 | 28.85 | Upgrade
|
Net Cash Growth | -0.11% | -60.51% | 33.70% | -32.10% | 338.41% | 120.69% | Upgrade
|
Net Cash Per Share | 0.68 | 1.02 | 3.61 | 3.63 | 8.07 | 3.74 | Upgrade
|
Filing Date Shares Outstanding | 90.08 | 89.93 | 44.4 | 27.91 | 21.17 | 10.74 | Upgrade
|
Total Common Shares Outstanding | 90.08 | 45.18 | 39.31 | 26.34 | 21.17 | 10.74 | Upgrade
|
Working Capital | 39.91 | 27.81 | 112.79 | 93.59 | 125.35 | 25.16 | Upgrade
|
Book Value Per Share | 0.46 | 0.64 | 2.89 | 4.83 | 7.50 | 5.43 | Upgrade
|
Tangible Book Value | 41.22 | 28.93 | 113.68 | 94.15 | 125.82 | 25.39 | Upgrade
|
Tangible Book Value Per Share | 0.46 | 0.64 | 2.89 | 3.57 | 5.94 | 2.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.